Regulatory disclosure submitted to BSE Limited regarding an upcoming board meeting. The Board of Directors meeting is scheduled to be held on Saturday, October 31, 2026. The primary agenda is to consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended on September 30, 2026.
In accordance with the Company's Code of Conduct for prohibition of insider trading, the Trading Window for dealing/trading in the company's shares was closed from October 1, 2026. The Trading Window will remain closed until 48 hours after the declaration of the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2026.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The letter was digitally signed by Akanksha, who holds the position of Company Secretary and Compliance Officer of Shree Ganesh Remedies Limited.